Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Cerilliant
Chinese Patent Office
Moodys
Colorcon
Dow
UBS
Farmers Insurance
McKesson

Generated: May 25, 2018

DrugPatentWatch Database Preview

Chloroquine hydrochloride - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for chloroquine hydrochloride and what is the scope of chloroquine hydrochloride freedom to operate?

Chloroquine hydrochloride
is the generic ingredient in one branded drug marketed by Sanofi Aventis Us and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for chloroquine hydrochloride.
Summary for chloroquine hydrochloride
Synonyms for chloroquine hydrochloride
1,4-Pentanediamine, N(sup 4)-(7-chloro-4-quinolinyl)-N(sup 1),N(sup 1)-diethyl-, dihydrochloride
1,4-Pentanediamine, N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-, dihydrochloride
1,4-Pentanediamine, N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-, dihydrochloride (9CI)
3545-67-3
4-((4-Amino-1-methylbutyl)amino)-7-chloroquinoline dihydrochloride
4-N-(7-chloroquinolin-4-yl)-1-N,1-N-diethylpentane-1,4-diamine dihydrochloride
7-(Chloro-4-((4-diethylamino)-1-methylbutyl)amino)quinoline dihydrochloride
AC1L368R
AC1Q3ADG
ACM3545673
Aralen hydrochloride
Aralen hydrochloride (TN)
C18H26ClN3.HCl
Chloroquine dihydrochloride
Chloroquine HCl
Chloroquine hydrochloride (USP)
Chloroquine hydrochloride [USAN]
Chloroquine hydrochloride [USP]
CTK8I3804
D03469
EINECS 222-592-1
LS-141311
N4-(7-Chloro-4-quinolyl)-N1,N1-diethylpentane-1,4-diamine dihydrochloride
n4-(7-chloroquinolin-4-yl)-n1,n1-diethylpentane-1,4-diamine dihydrochloride
Quinoline, 4-((4-amino-1-methylbutyl)amino)-7-chloro-, dihydrochloride
SCHEMBL9862220

US Patents and Regulatory Information for chloroquine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us ARALEN HYDROCHLORIDE chloroquine hydrochloride INJECTABLE;INJECTION 006002-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Farmers Insurance
Express Scripts
Mallinckrodt
Queensland Health
Teva
McKesson
Cerilliant
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.